Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-006274

Options or other derivatives

  • President and CEO acquired 1,165,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-15 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +1,165,100 1,165,100 D
Loading xslF345X03/ownership.xml…